Researchers sought to determine what genetic factors may prompt a refractory response to ondansetron in pediatric patients with cancer.
Researchers sought to determine predictors for survival among hematologic cancer patients with septic shock.
Analysis of data from 2 clinical trials sought to determine the effect on symptom burden of 2 common therapies for myeloproliferative neoplasms.
Treatment of fatigue related to high-grade glioma using armodafinil did not show a meaningful benefit over placebo in a phase 3 trial.
During 2014 to 2018, incidence continued to increase slowly for female breast cancer, remained stable for prostate cancer
Researchers sought to determine the effects of commonly used interventions on 2 significant symptoms experienced by patients with leukemia.
The guideline focuses on managing treatment of cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome in patients undergoing CAR-T therapy for hematologic cancers.
A head-to-head comparison was conducted to determine the safety and efficacy of fosnetupitant with fosaprepitant in combination with palonosetron and dexamethasone.
A retrospective analysis of data identified predictors of cardiac adverse events in patients with CML undergoing treatment with tyrosine kinase inhibitors.
Researchers sought to determine the potential risk of cardiovascular mortality vs risk of disease recurrence in patients with early-stage HL receiving IFRT after ABVD.